DISCUVA LIMITED

Company Number		06169490
Company ID Number		06169490
Date formed		2007-03-19
Country		ENGLAND
Origin Country		United Kingdom
Type		Private Limited Company
CompanyStatus		Active
Lastest accounts		31/12/2023
Account next due		30/09/2025
Latest return		19/03/2016
Return next due		16/04/2017
Type of accounts		FULL
VAT Number /Sales tax ID		GB122983705

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of DISCUVA LIMITED

Current Directors

Officer	Role	Date Appointed
MELISSA CLAIRE STRANGE	Company Secretary	2017-12-23
GLYN OWAIN EDWARDS	Director	2017-12-23

Previous Officers

Officer	Role	Date Appointed	Date Resigned
TIMOTHY CHARLES BULLOCK	Director	2011-12-02	2017-12-23
IAN MICHAEL RIORDEN GEORGE	Director	2011-12-02	2017-12-23
URSULA MARY NEY	Director	2016-03-23	2017-12-23
ERNESTO GIORGIO REGGIANI	Director	2011-12-02	2017-12-23
JOHN RICHARD WAIN	Director	2011-12-02	2017-12-23
DAVID HUGH WILLIAMS	Director	2007-03-19	2017-12-23
PAUL ANTHONY NEWEY	Director	2012-12-20	2014-02-26
DEIRDRE LESLEY JOYCE WILLIAMS	Company Secretary	2007-03-19	2011-10-31
SDG SECRETARIES LIMITED	Nominated Secretary	2007-03-19	2007-03-19
SDG REGISTRARS LIMITED	Nominated Director	2007-03-19	2007-03-19

Related Directorships

Officer	Related Company	Role	Date Appointed	Role Status	Incorporation date	Company Status
GLYN OWAIN EDWARDS	SUMMIT INFECTIOUS DISEASES LIMITED	Director	2018-01-17	CURRENT	2018-01-17	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	OXSONICS LIMITED	Director	2017-10-01	CURRENT	2013-07-03	Active
GLYN OWAIN EDWARDS	SUMMIT CORPORATION LIMITED	Director	2014-10-31	CURRENT	2014-10-31	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	MUOX LIMITED	Director	2013-11-22	CURRENT	2012-12-20	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	SUMMIT (CAMBRIDGE) LIMITED	Director	2012-04-04	CURRENT	2001-07-24	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	SUMMIT (OXFORD) LIMITED	Director	2012-04-04	CURRENT	2003-01-14	Active
GLYN OWAIN EDWARDS	SUMMIT THERAPEUTICS LIMITED	Director	2012-04-04	CURRENT	2004-08-04	Active
GLYN OWAIN EDWARDS	SUMMIT (WALES) LIMITED	Director	2012-04-04	CURRENT	2007-02-19	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	SUMMIT CORPORATION EMPLOYEE BENEFIT TRUST COMPANY LIMITED	Director	2012-04-04	CURRENT	2009-12-09	Active - Proposal to Strike off
GLYN OWAIN EDWARDS	SUMMIT DISCOVERY 1 LIMITED	Director	2012-04-04	CURRENT	2005-11-25	Active - Proposal to Strike off

More director information

Corporation Filing History

Companies House Filing History

This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

Date	Document Type	Document Description
2024-09-28		FULL ACCOUNTS MADE UP TO 31/12/23
2024-04-26		DIRECTOR APPOINTED BHASKAR ANAND
2024-04-25		APPOINTMENT TERMINATED, DIRECTOR ANKUR DHINGRA
2024-03-19		CONFIRMATION STATEMENT MADE ON 19/03/24, WITH UPDATES
2024-03-12		Resolutions passed:<ul><li>Resolution Capitalise 2,633,809 11/03/2024<li>Resolution reduction in capital</ul>
2024-03-12		Solvency Statement dated 11/03/24
2024-03-12		Statement by Directors
2024-03-12		Statement of capital on GBP 0.002
2024-03-12		12/03/24 STATEMENT OF CAPITAL GBP 1458507.002
2024-03-12		Resolutions passed:<ul><li>Resolution Capitalise 1,458,507,000 shares of 0.001 each 12/03/2024</ul>
2024-03-12		Resolutions passed:<ul><li>Resolution Capitalise 1,458,507,000 shares of 0.001 each 12/03/2024<li>Resolution Declare final dividend 12/03/2024</ul>
2024-03-12		Resolutions passed:<ul><li>Resolution Capitalise 1,458,507,000 shares of 0.001 each 12/03/2024<li>Resolution Declare final dividend 12/03/2024<li>Resolution reduction in capital</ul>
2024-03-12		Solvency Statement dated 12/03/24
2024-03-11		Resolutions passed:<ul><li>Resolution Capitalise 2,633,809 08/03/2024</ul>
2024-03-11		Resolutions passed:<ul><li>Resolution Capitalise 2,633,809 08/03/2024<li>Resolution reduction in capital</ul>
2024-03-11		Solvency Statement dated 08/03/24
2024-03-11		Statement by Directors
2024-03-11		Statement of capital on GBP 0.002
2024-03-11		11/03/24 STATEMENT OF CAPITAL GBP 2633809.002
2024-03-11		Resolutions passed:<ul><li>Resolution on securities</ul>
2024-03-11		Resolutions passed:<ul><li>Resolution on securities<li>Resolution reduction in capital</ul>
2024-03-11		Solvency Statement dated 11/03/24
2024-03-08		Statement by Directors
2024-03-08		Solvency Statement dated 07/03/24
2024-03-08		Resolutions passed:<ul><li>Resolution Reduce share premium 07/03/2024</ul>
2024-03-08		Resolutions passed:<ul><li>Resolution Reduce share premium 07/03/2024<li>Resolution reduction in capital</ul>
2024-03-08		Statement of capital on GBP 0.002
2024-03-08		08/03/24 STATEMENT OF CAPITAL GBP 2633809.002
2023-12-14		DIRECTOR APPOINTED MANMEET SINGH SONI
2023-08-23		FULL ACCOUNTS MADE UP TO 31/12/22
2023-04-18		CONFIRMATION STATEMENT MADE ON 19/03/23, WITH NO UPDATES
2022-10-04		FULL ACCOUNTS MADE UP TO 31/12/21
2022-10-04	AA	FULL ACCOUNTS MADE UP TO 31/12/21
2022-08-19	AP01	DIRECTOR APPOINTED MR ANKUR DHINGRA
2022-08-19	TM01	APPOINTMENT TERMINATED, DIRECTOR CAMPBELL HAIR
2022-04-28		APPOINTMENT TERMINATED, DIRECTOR ROBERT WILLIAM DUGGAN
2022-04-28		CONFIRMATION STATEMENT MADE ON 19/03/22, WITH NO UPDATES
2022-04-28	CS01	CONFIRMATION STATEMENT MADE ON 19/03/22, WITH NO UPDATES
2022-04-28	TM01	APPOINTMENT TERMINATED, DIRECTOR ROBERT WILLIAM DUGGAN
2022-01-21		APPOINTMENT TERMINATED, DIRECTOR JEFFREY MARANIAN
2022-01-21	TM01	APPOINTMENT TERMINATED, DIRECTOR JEFFREY MARANIAN
2022-01-19		APPOINTMENT TERMINATED, DIRECTOR DAVID JONATHAN POWELL
2022-01-19		DIRECTOR APPOINTED MR JEFFREY MARANIAN
2022-01-19		DIRECTOR APPOINTED MR CAMPBELL HAIR
2022-01-19	AP01	DIRECTOR APPOINTED MR JEFFREY MARANIAN
2022-01-19	TM01	APPOINTMENT TERMINATED, DIRECTOR DAVID JONATHAN POWELL
2021-09-09	AA	FULL ACCOUNTS MADE UP TO 31/12/20
2021-06-08	TM02	Termination of appointment of Hugh Feargal O'neill on 2021-06-08
2021-03-24	CS01	CONFIRMATION STATEMENT MADE ON 19/03/21, WITH UPDATES
2021-03-24	PSC05	Change of details for Summit Therapeutics Plc as a person with significant control on 2020-09-18
2021-02-22	AP01	DIRECTOR APPOINTED DR DAVID JONATHAN POWELL
2021-02-11	TM01	APPOINTMENT TERMINATED, DIRECTOR VENTZISLAV KIRILOV STEFANOV
2020-09-08	RES11	Resolutions passed: Resolution of removal of pre-emption rights Resolution of allotment of securities
2020-09-07	SH01	14/08/20 STATEMENT OF CAPITAL GBP 832244.258
2020-07-07	AA	FULL ACCOUNTS MADE UP TO 31/12/19
2020-07-07	AA	FULL ACCOUNTS MADE UP TO 31/12/19
2020-06-30	AP03	Appointment of Hugh Feargal O'neill as company secretary on 2020-06-30
2020-06-30	AP03	Appointment of Hugh Feargal O'neill as company secretary on 2020-06-30
2020-06-30	TM02	Termination of appointment of Melissa Claire Strange on 2020-06-30
2020-06-30	TM02	Termination of appointment of Melissa Claire Strange on 2020-06-30
2020-06-05	AP01	DIRECTOR APPOINTED DR VENTZISLAV KIRILOV STEFANOV
2020-06-05	AP01	DIRECTOR APPOINTED DR VENTZISLAV KIRILOV STEFANOV
2020-06-05	TM01	APPOINTMENT TERMINATED, DIRECTOR ROBERT WILLIAM DUGGAN
2020-06-05	TM01	APPOINTMENT TERMINATED, DIRECTOR ROBERT WILLIAM DUGGAN
2020-04-24	CS01	CONFIRMATION STATEMENT MADE ON 19/03/20, WITH NO UPDATES
2019-12-20	AA01	Current accounting period shortened from 31/01/20 TO 31/12/19
2019-06-27	AA	FULL ACCOUNTS MADE UP TO 31/01/19
2019-03-21	CS01	CONFIRMATION STATEMENT MADE ON 19/03/19, WITH UPDATES
2019-02-15	SH02	Sub-division of shares on 2019-01-30
2019-02-15	SH01	30/01/19 STATEMENT OF CAPITAL GBP 832244.257
2019-02-15	SH08	Change of share class name or designation
2019-02-15	SH10	Particulars of variation of rights attached to shares
2019-02-14	RES11	Resolutions passed: Resolution of removal of pre-emption rights Resolution of varying share rights or name Resolution of allotment of securities
2018-08-01	AA	FULL ACCOUNTS MADE UP TO 31/01/18
2018-05-04	CS01	CONFIRMATION STATEMENT MADE ON 19/03/18, WITH UPDATES
2018-02-20	RES01	ADOPT ARTICLES 20/02/18
2018-01-22	PSC02	Notification of Summit Therapeutics Plc as a person with significant control on 2017-12-23
2018-01-22	PSC07	CESSATION OF NEW WAVE VENTURES LLP AS A PERSON OF SIGNIFICANT CONTROL
2018-01-18	SH01	22/12/17 STATEMENT OF CAPITAL GBP 54668.624
2018-01-18	LATEST SOC	18/01/18 STATEMENT OF CAPITAL;GBP 55531.137
2018-01-18	SH01	23/12/17 STATEMENT OF CAPITAL GBP 55531.137
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR DAVID WILLIAMS
2018-01-09	AA01	Current accounting period shortened from 31/03/18 TO 31/01/18
2018-01-09	AD01	REGISTERED OFFICE CHANGED ON 09/01/18 FROM The Merrifield Centre Rosemary Lane Cambridge CB1 3LQ
2018-01-09	AP03	Appointment of Mrs Melissa Claire Strange as company secretary on 2017-12-23
2018-01-09	AP01	DIRECTOR APPOINTED MR GLYN OWAIN EDWARDS
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR ERNESTO REGGIANI
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR JOHN WAIN
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR URSULA NEY
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR IAN GEORGE
2018-01-09	TM01	APPOINTMENT TERMINATED, DIRECTOR TIMOTHY BULLOCK
2018-01-04	MEM/ARTS	ARTICLES OF ASSOCIATION
2017-12-22	LATEST SOC	22/12/17 STATEMENT OF CAPITAL;GBP 54668.623
2017-12-22	SH19	22/12/17 STATEMENT OF CAPITAL GBP 54668.623
2017-12-22	SH20	STATEMENT BY DIRECTORS
2017-12-22	CAP-SS	SOLVENCY STATEMENT DATED 22/12/17
2017-12-22	RES06	REDUCE ISSUED CAPITAL 22/12/2017
2017-12-19	AA	31/03/17 UNAUDITED ABRIDGED
2017-12-08	MR04	STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE NO 1
2017-03-20	LATEST SOC	20/03/17 STATEMENT OF CAPITAL;GBP 3309999.493
2017-03-20	CS01	CONFIRMATION STATEMENT MADE ON 19/03/17, WITH UPDATES
2016-12-20	AA	31/03/16 TOTAL EXEMPTION SMALL
2016-04-11	AP01	DIRECTOR APPOINTED DR URSULA NEY
2016-03-21	LATEST SOC	21/03/16 STATEMENT OF CAPITAL;GBP 3309999.493
2016-03-21	AR01	19/03/16 FULL LIST
2015-12-15	AA	31/03/15 TOTAL EXEMPTION SMALL
2015-04-20	LATEST SOC	20/04/15 STATEMENT OF CAPITAL;GBP 3309999.493
2015-04-20	AR01	19/03/15 FULL LIST
2014-12-03	MR05	STATEMENT OF RELEASE / CEASE FROM CHARGE / WHOLE BOTH / CHARGE NO 1
2014-12-01	AA	31/03/14 TOTAL EXEMPTION SMALL
2014-04-01	LATEST SOC	01/04/14 STATEMENT OF CAPITAL;GBP 3309999.493
2014-04-01	AR01	19/03/14 FULL LIST
2014-04-01	TM01	APPOINTMENT TERMINATED, DIRECTOR PAUL NEWEY
2014-02-25	AD01	REGISTERED OFFICE CHANGED ON 25/02/2014 FROM 260 SCIENCE PARK, MILTON ROAD CAMBRIDGE CB4 0WE ENGLAND
2014-01-05	AA	31/03/13 TOTAL EXEMPTION SMALL
2013-03-19	AR01	19/03/13 FULL LIST
2013-01-08	RES12	VARYING SHARE RIGHTS AND NAMES
2013-01-08	RES01	ADOPT ARTICLES 19/12/2012
2012-12-27	AP01	DIRECTOR APPOINTED MR PAUL ANTHONY NEWEY
2012-12-27	SH01	20/12/12 STATEMENT OF CAPITAL GBP 2009999.843
2012-08-03	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2012-08-03	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2012-07-25	AA	31/03/12 TOTAL EXEMPTION SMALL
2012-04-11	AR01	19/03/12 FULL LIST
2012-01-06	AA	ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/03/11
2012-01-05	AD01	REGISTERED OFFICE CHANGED ON 05/01/2012 FROM REDCOTE HOUSE, 56 ORCHARD ROAD MELBOURN HERTS SG8 6BB
2012-01-05	MG01	PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1
2011-12-12	RES11	DISAPPLICATION OF PRE-EMPTION RIGHTS
2011-12-12	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-12-09	MEM/ARTS	ARTICLES OF ASSOCIATION
2011-12-09	RES10	AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2011-12-09	RES12	VARYING SHARE RIGHTS AND NAMES
2011-12-06	AP01	DIRECTOR APPOINTED PROFESSOR JOHN RICHARD WAIN
2011-12-05	AP01	DIRECTOR APPOINTED MR IAN MICHAEL RIORDEN GEORGE
2011-12-05	AP01	DIRECTOR APPOINTED MR TIMOTHY CHARLES BULLOCK
2011-12-05	AP01	DIRECTOR APPOINTED MR ERNESTO GIORGIO REGGIANI
2011-12-05	SH01	02/12/11 STATEMENT OF CAPITAL GBP 2009999.84
2011-11-21	TM02	APPOINTMENT TERMINATED, SECRETARY DEIRDRE WILLIAMS
2011-11-10	SH01	22/07/11 STATEMENT OF CAPITAL GBP 10000
2011-07-29	SH02	SUB-DIVISION 20/07/11
2011-04-14	AR01	19/03/11 FULL LIST
2011-01-10	RES15	CHANGE OF NAME 09/01/2011
2011-01-10	CERTNM	COMPANY NAME CHANGED OMACROM LIMITED CERTIFICATE ISSUED ON 10/01/11
2011-01-03	AA	ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/03/10
2010-04-30	AR01	19/03/10 FULL LIST
2010-04-30	CH01	DIRECTOR'S CHANGE OF PARTICULARS / DR DAVID HUGH WILLIAMS / 19/03/2010
2010-01-09	AA	ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/03/09
2009-03-23	363a	RETURN MADE UP TO 19/03/09; FULL LIST OF MEMBERS
2008-12-22	AA	ACCOUNTS OF DORMANT COMPANY MADE UP TO 31/03/08
2008-03-25	363a	RETURN MADE UP TO 19/03/08; FULL LIST OF MEMBERS
2008-03-21	88(2)	AD 19/03/07 GBP SI 1@1=1 GBP IC 1/2
2007-03-30	288a	NEW DIRECTOR APPOINTED
2007-03-30	288b	DIRECTOR RESIGNED
2007-03-30	288b	SECRETARY RESIGNED
2007-03-30	288a	NEW SECRETARY APPOINTED
2007-03-19	NEWINC	INCORPORATION DOCUMENTS CERTIFICATE OF INCORPORATION STATEMENT OF DIRECTORS & REGISTERED OFFICE DECLARATION OF COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION

Industry Information

SIC/NAIC Codes

72 - Scientific research and development

721 - Research and experimental development on natural sciences and engineering

72110 - Research and experimental development on biotechnology

Licences & Regulatory approval

We could not find any licences issued to DISCUVA LIMITED or authorisation from an industry specific regulator to operate. These may not be required.

Share this page on Facebook

Risks

Legal Notices

No legal notices or events such as winding-up orders or proposals to strike-off have been issued

Fines / Sanctions

No fines or sanctions have been issued against DISCUVA LIMITED

Liabilities

Mortgages / Charges

Total # Mortgages/Charges	1
Mortgages/Charges outstanding	0
Mortgages Partially Satisifed	0
Mortgages Satisfied/Paid	1

Details of Mortgagee Charges

Charge Type	Date of Charge	Charge Status	Mortgagee
RENT DEPOSIT DEED	2012-01-05	ALL of the property or undertaking has been released and no longer forms part of the charge	THE MASTER FELLOWS AND SCHOLARS OF TRINITY COLLEGE CAMBRIDGE

Filed Financial Reports

Annual Accounts
2014-03-31

Annual Accounts
2015-03-31

Annual Accounts
2016-03-31

Annual Accounts
2017-03-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on DISCUVA LIMITED

Intangible Assets

Patents

We have not found any records of DISCUVA LIMITED registering or being granted any patents

Domain Names

We do not have the domain name information for DISCUVA LIMITED

Trademarks

We have not found any records of DISCUVA LIMITED registering or being granted any trademarks

Income

Government Income

We have not found government income sources for DISCUVA LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as DISCUVA LIMITED are:

Outgoings

Business Rates/Property Tax

No properties were found where DISCUVA LIMITED is liable for the business rates / property tax. This could be for a number of reasons.

The council hasnt published the data
We havent found or been able to process the councils data
The company is part of a group of companies and another company in the group is liable for business rates
The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.

Import/Export of Goods

Goods imported/exported by DISCUVA LIMITED

Date	Import Code	Imported Goods classification description
2015-07-01	29321900	Heterocyclic compounds with oxygen hetero-atom[s] only, containing an unfused furan ring, whether or not hydrogenated, in the structure (excl. tetrahydrofuran, 2-furaldehyde "furfuraldehyde", furfuryl alcohol and tetrahydrofurfuryl alcohol)
2014-04-01	84799080	Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel)
2013-10-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2013-04-01	29339980	Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2013-02-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2012-11-01	38220000	Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Government Grants / Awards

Technology Strategy Board Awards

DISCUVA LIMITED has been awarded 1 awards from the Technology Strategy Board. The value of these awards is £ 1,620,000

Category	Award Date	Award/Grant
Discovery of New Commercially Valuable Antibiotics to Treat Bacterial Infection : Feasibility Study	2012-12-01	£ 1,620,000

How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.

European Union CORDIS Awards

The European Union has not awarded DISCUVA LIMITED any grants or awards.

Ownership

We could not find any group structure information

Is this data useful to you?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Need more information?

We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.

Last Datalog update:	2024-10-05 16:39:09
Primary Source:	Companies House

Company Overview

Company Officers of DISCUVA LIMITED

Related Directorships